BFC Planning, Inc.’s Cogent Biosciences COGT Stock Holding History

BFC Planning, Inc.’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56K	Hold	92	–	–	﹤0.01%	2808
2026 Q1	$3.54K	Buy	+92	New	+$3.4K	﹤0.01%	2433

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFC Planning, Inc.'s COGT Position: Q2 2026 in Review

BFC Planning, Inc. held its Cogent Biosciences (COGT) position steady in Q2 2026 at 92 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

BFC Planning, Inc. first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. 326 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

BFC Planning, Inc. held 92 shares of Cogent Biosciences worth $3.56K as of Q2 2026.
BFC Planning, Inc. left its Cogent Biosciences share count unchanged in Q2 2026.
Cogent Biosciences made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2808 holding.
BFC Planning, Inc. first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
326 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.